Diabetic peripheral neuropathic pain: Clinical and quality-of-life issues

被引:190
作者
Argoff, CE
Cole, BE
Fishbain, DA
Irving, GA
机构
[1] Amer Soc Pain Educators, Montclair, NJ 07042 USA
[2] NYU, Sch Med, New York, NY USA
[3] Northshore Univ Hosp, Cohn Pain Management Ctr, Manhasset, NY USA
[4] Univ Miami, Sch Med, Dept Psychiat, Miami, FL 33152 USA
[5] Univ Miami, Sch Med, Dept Neurol Surg, Miami, FL 33152 USA
[6] Univ Miami, Sch Med, Dept Anesthesiol, Miami, FL 33152 USA
[7] Univ Washington, Dept Anesthesiol, Sch Med, Seattle, WA 98195 USA
[8] Swedish Med Ctr, Swedish Pain Management Serv, Seattle, WA USA
关键词
D O I
10.1016/S0025-6196(11)61474-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic peripheral neuropathy (DPN) Is estimated to be present in 50% of people living with diabetes mellitus (DM). Comorbidities of DM, such as macrovascular and microvascular changes, also Interact with DPN and affect Its course. In patients with DM, DPN Is the leading cause of foot ulcers, which In turn are a major cause of amputation In the United States. Although most patients with DPN do not have pain, approximately 11% of patients with DPN have chronic, painful symptoms that diminish quality of life, disrupt sleep, and can lead to depression. Despite the number of patients affected by DPN pain, little consensus exists about the pathophysiology, best diagnostic tools, and primary treatment choices. This article reviews the current knowledge about and presents recommendations for diagnostic assessment of DPN pain based on a review of the literature.
引用
收藏
页码:S3 / S11
页数:9
相关论文
共 57 条
  • [51] The spectrum of neuropathy in diabetes and impaired glucose tolerance
    Sumner, CJ
    Sheth, S
    Griffin, JW
    Cornblath, DR
    Polydefkis, M
    [J]. NEUROLOGY, 2003, 60 (01) : 108 - 111
  • [52] Vascular risk factors and diabetic neuropathy
    Tesfaye, S
    Chaturvedi, N
    Eaton, SEM
    Ward, JD
    Manes, C
    Ionescu-Tirgoviste, C
    Witte, DR
    Fuller, JH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (04) : 341 - 350
  • [53] Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    Turner, RC
    Holman, RR
    Cull, CA
    Stratton, IM
    Matthews, DR
    Frighi, V
    Manley, SE
    Neil, A
    McElroy, K
    Wright, D
    Kohner, E
    Fox, C
    Hadden, D
    Mehta, Z
    Smith, A
    Nugent, Z
    Peto, R
    Adlel, AI
    Mann, JI
    Bassett, PA
    Oakes, SF
    Dornan, TL
    Aldington, S
    Lipinski, H
    Collum, R
    Harrison, K
    MacIntyre, C
    Skinner, S
    Mortemore, A
    Nelson, D
    Cockley, S
    Levien, S
    Bodsworth, L
    Willox, R
    Biggs, T
    Dove, S
    Beattie, E
    Gradwell, M
    Staples, S
    Lam, R
    Taylor, F
    Leung, L
    Carter, RD
    Brownlee, SM
    Fisher, KE
    Islam, K
    Jelfs, R
    Williams, PA
    Williams, FA
    Sutton, PJ
    [J]. LANCET, 1998, 352 (9131) : 837 - 853
  • [54] Vinik AI, 2004, MED CLIN N AM, V88, P947, DOI 10.1212/01.CON.0000455884.29545.d2
  • [55] Pain: Moving from symptom control toward mechanism-specific pharmacologic management
    Woolf, CJ
    [J]. ANNALS OF INTERNAL MEDICINE, 2004, 140 (06) : 441 - 451
  • [56] Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy
    Zelman, DC
    Dukes, E
    Brandenburg, N
    Bostrom, A
    Gore, M
    [J]. PAIN, 2005, 115 (1-2) : 29 - 36
  • [57] Validation of a modified version of the Brief Pain Inventory for painful diabetic peripheral neuropathy
    Zelman, DC
    Gore, M
    Dukes, E
    Tai, KS
    Brandenburg, N
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2005, 29 (04) : 401 - 410